![Marion Dorsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marion Dorsch
President chez Atavistik Bio, Inc.
Postes actifs de Marion Dorsch
Sociétés | Poste | Début | Fin |
---|---|---|---|
Atavistik Bio, Inc.
![]() Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Directeur Technique/Scientifique/R&D | 01/04/2021 | - |
President | 01/04/2021 | - |
Historique de carrière de Marion Dorsch
Anciens postes connus de Marion Dorsch
Sociétés | Poste | Début | Fin |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Directeur Technique/Scientifique/R&D | 21/11/2016 | 01/03/2021 |
AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2012 | 01/11/2016 |
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01/01/2010 | 01/04/2012 |
Formation de Marion Dorsch
Freie Universität Berlin | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Allemagne | 2 |
France | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Atavistik Bio, Inc.
![]() Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Health Technology |
- Bourse
- Insiders
- Marion Dorsch
- Expérience